Abstract:Objective To evaluate the surgical outcomes and prognosis of patients after liver resection for noncolorectal liver metastases.Methods 72 patients with liver metastases who underwent liver resection at Tianjin Medical University Cancer Hospital were retrospectively studied.There were 32 males and 42 females,aged between 35～78 years.After liver resection,68 patients had a R0 resection (negative histological margin),and 4 patients had a R1 resection (positive histological margin).The primary tumours were breast,(n =16,22.2 ％),lung (n =14,19.4 ％),gastrointestinal (n=12,16.7％),gynecological (n =8,11.1％),pancreatobiliary (n =8,11.1％),melanoma (n=4,5.6％),sarcoma (n=4,5.6％),and genitourinary (n=2,2.8％).The mean diameter of the main tumour was 4.8 cm (range,1.5- 11.0 cm).The mean number of liver metastases was 1.2 (range,1-5).Liver metastases were synchronous in 6 patients (8.3％) and metachronous in the remaining 66 patients (91.7％).Results The operative mortality was 0％.The mean hospital stay was 14.4 days (range 6-67 days).The median overall survival was 31 months (range,6-127 months).The 1-,3- and 5-year survival rates were 81.9％,37.5％ and 23.6％,respectively.Univariate analysis revealed primary tumour sites (breast vs.others),histological type (adenocarcinoma vs.others),postoperative chemotherapy,number of liver metastases (solitary vs.multiple) and time to liver metastases from diagnosis of primary tumours (≤ 12 months vs.＞ 12 months) were associated with overall survival (all,P＜0.05).In multivariate analysis,factors independently associated with poor survival were nonbreast origin (P =0.012),time to liver metastases from diagnosis of primary tumours ＜12 months (P=0.027) and multiple liver metastases (P=0.008).Conclusions In selected patients,liver resection is an effective and safe treatment for noncolorectal liver metastases.The time to liver metastases from diagnosis of primary tumours was independently associated with overall survival.For solitary or liver metastasis of breast origin,surgical resection significantly improved survival.

Hepatic Resection for Recurrent Metastatic Ovarian Carcinoma or Peritoneal Carcinoma: a Retrospective Case-Control Study

Significance of Hepatic Resection in the Treatment of Hepatic Parenchymal Metastasis of Recurrent Epithelial Ovarian Carcinoma

Retrospective Analysis on 682 Cases of Liver Cancer after Surgical Treatment

Surgical Treatment and Outcome of Ovarian Cancer Patients With Liver Metastases: Experience of a Tertiary Hepatic and Peritoneal Surface Malignancy Center

Extra-Abdominal Metastases from Epithelial Ovarian Carcinoma an Analysis of 20 Cases

Hepatic Resection for Synchronous Hepatic Metastasis from Gastric Cancer

[Evaluation of Long-Term Survival after Hepatic Resection for Metastatic Colorectal Cancer-a Multifactorial Model of 191 Patients].

A Retrospective Analysis of Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy in Patients with Recurrent Ovarian Cancer

Hepatectomy for Liver Metastasis of Colorectal Cancer

Long-Term Outcomes of Surgical Resection for Liver Metastasis from Breast Cancer.

[Surgical Treatment for Hepatic Metastases from Colorectal Carcinoma].

Primary Tumor Resection for Rectal Cancer With Unresectable Liver Metastases: A Chance to Cut Is a Chance for Improved Survival

Prognostic Analysis of Surgical Resection for Patients with Liver Metastases from Gastric Cancer

Liver Resection for Noncolorectal Liver Metastases: an Analysis of 72 Patients

Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer

Survival Impact of Secondary Cytoreductive Surgery for Platinum-Sensitive Relapsed Serous Ovarian Cancer.

The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis

Therapeutic Effects of Hepatic Resection in Liver Metastasis of Colorectal Cancer

Surgical resection of late extrahepatic metastasis of hepatocellular carcinoma 11 years after initial diagnosis: case report and literature review

Surgical Treatment of Recurrent Hepatocellular Carcinoma.

Hepatic cytoreduction for lung and renal neuroendocrine tumor metastases